Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPathogenesis and management of myeloma bone disease
Expert Review of Hematology, 08/17/09
Christoulas D et al. – Bisphosphonates are the mainstay of treatment for myeloma bone disease, although several novel agents appear promising. This review focuses on recent advances in understanding the biology of bone disease in multiple myeloma, diagnosis and recent progress in treatment options.
Related Articles
Mikuliczs disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
International Journal of Hematology, 10/30/09
Relevance Score: 79%
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 79%
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
British Journal of Haematology, 10/16/09
Relevance Score: 79%
Combined Histocompatibility Leukocyte Antigenmatched Donor Bone Marrow and Renal Transplantation for Multiple Myeloma With End Stage Renal Disease: the Induction of Allograft Tolerance Through Mixed Lymphohematopoietic Chimerism
Transplantation, 10/08/09
Relevance Score: 79%
Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases
Mayo Clinic Proceedings, 10/09/09
Relevance Score: 69%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
Oncogene, 12/16/09
Mechanisms of breast cancer bone metastasis
Cancer Letters, 12/16/09
Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine
Clinical Cancer Research, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor